We are live on ! Find out more
MLAB icon

Mesa Laboratories

175 hedge funds and large institutions have $1.24B invested in Mesa Laboratories in 2022 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 69 increasing their positions, 57 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

21% more repeat investments, than reductions

Existing positions increased: 69 | Existing positions reduced: 57

0.95% more ownership

Funds ownership: 91.62%92.56% (+0.95%)

0% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 17

2% less funds holding

Funds holding: 178175 (-3)

21% less capital invested

Capital invested by funds: $1.57B → $1.24B (-$331M)

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

Holders
175
Holders Change
-3
Holders Change %
-1.69%
% of All Funds
2.76%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
17
Increased
69
Reduced
57
Closed
17
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Charles Schwab
26
Charles Schwab
California
$9.54M +$248K +912 +2%
RJA
27
Raymond James & Associates
Florida
$8.84M +$1.26M +4,656 +15%
Bank of America
28
Bank of America
North Carolina
$7.59M -$708K -2,608 -8%
PI
29
Putnam Investments
Massachusetts
$7.25M -$38.8K -143 -0.5%
Morgan Stanley
30
Morgan Stanley
New York
$6.72M +$1.31M +4,829 +22%
Royal Bank of Canada
31
Royal Bank of Canada
Ontario, Canada
$6.52M +$330K +1,216 +5%
N
32
Nuveen
North Carolina
$4.66M -$177K -650 -4%
RJFSA
33
Raymond James Financial Services Advisors
Florida
$4.43M +$50.8K +187 +1%
JP Morgan Chase
34
JP Morgan Chase
New York
$3.83M -$124K -455 -3%
Citadel Advisors
35
Citadel Advisors
Florida
$3.78M +$3.61M +13,291 +864%
Victory Capital Management
36
Victory Capital Management
Texas
$3.68M +$443K +1,633 +12%
AllianceBernstein
37
AllianceBernstein
Tennessee
$3.65M +$29.9K +110 +0.8%
RhumbLine Advisers
38
RhumbLine Advisers
Massachusetts
$3.59M +$25.3K +93 +0.7%
Luther King Capital Management (LKCM)
39
Luther King Capital Management (LKCM)
Texas
$3.54M
Renaissance Technologies
40
Renaissance Technologies
New York
$3.34M -$756K -2,782 -18%
Legal & General Group
41
Legal & General Group
United Kingdom
$3.24M -$20.1K -74 -0.6%
PPA
42
Parametric Portfolio Associates
Washington
$3.22M -$142K -523 -4%
Swiss National Bank
43
Swiss National Bank
Switzerland
$3.16M +$244K +900 +8%
US Bancorp
44
US Bancorp
Minnesota
$3.09M +$178K +657 +6%
Envestnet Asset Management
45
Envestnet Asset Management
Illinois
$2.87M +$406K +1,495 +15%
RHJA
46
Rice Hall James & Associates
California
$2.81M
MFAM
47
Motley Fool Asset Management
Virginia
$2.74M -$702K -2,584 -19%
Millennium Management
48
Millennium Management
New York
$2.69M +$640K +2,358 +29%
Ohio Public Employees Retirement System (OPERS)
49
Ohio Public Employees Retirement System (OPERS)
Ohio
$2.62M
Goldman Sachs
50
Goldman Sachs
New York
$2.53M -$479K -1,764 -15%

MLAB Hedge Fund Activity: Q1 2022 in Review

175 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Mesa Laboratories (MLAB) for Q1 2022, worth a combined $1.24B — down 21% from $1.57B a quarter earlier.

Fund positioning in MLAB was balanced in Q1 2022: 17 funds opened new positions, 17 closed out, 69 added to existing stakes and 57 trimmed.

The largest buyer was Principal Financial Group, adding an estimated $5.98M. The largest seller was EAM Investors, exiting entirely with an estimated $3.18M sold.

  • 175 institutional investors held Mesa Laboratories (MLAB) as of Q1 2022, down from 178 in Q4 2021.
  • Funds reported $1.24B of Mesa Laboratories stock for Q1 2022, down 21% quarter-over-quarter.
  • 17 funds opened new Mesa Laboratories positions in Q1 2022 and 17 closed out, a net change of 0 holders.
  • The largest Mesa Laboratories buyer in Q1 2022 was Principal Financial Group, an estimated $5.98M added.
  • The largest Mesa Laboratories seller in Q1 2022 was EAM Investors, an estimated $3.18M sold.

Based on aggregated 13F filings for Q1 2022.